Facebook
Twitter
LinkedIn
Forward| GRAIL - Exhibitor | |
|---|---|
Contact information Jordan Stricker Kim Emery | GRAIL is a healthcare company whose mission is to detect cancer early when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. The company uses the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer and data science to overcome one of medicine’s greatest challenges. Their first product, the Galleri® multi-cancer early detection test, should be added to guideline-recommended screenings for adults with elevated risk for cancer. It detects a signal shared by more than 50 types of cancer through a routine blood draw. When a signal is detected, the Galleri test can predict the cancer signal origin. For more information and important safety information visit GRAIL.com or Galleri.com The Galleri® multi-cancer early detection test is the first product from GRAIL, a healthcare company whose mission is to detect cancer early when it can be cured. Using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer and data science to overcome one of medicine’s greatest challenges, GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. The Galleri® test should be added to guideline-recommended screenings, and can detect a signal shared by more than 50 types of cancer through a routine blood draw. When a signal is detected, the Galleri test can predict the cancer signal origin. For more information and important safety information visit Galleri.com.
Additional Information: |
